Results 1 to 10 of about 24,558,315 (312)

Development of pulmonary tuberculosis in the patient with systemic sarcoidosis and brain involvement

Туберкулез и болезни лёгких, 2021
The article presents a clinical case of pulmonary tuberculosis with destruction and bacterial excretion in the patient with systemic sarcoidosis and cerebral lesions.
E. V. Korzh, N. A. Podchos, S. A. Iskevich, O. E. Perederiy   +3 more
doaj   +1 more source

Treatment of multiple drug resistant pulmonary tuberculosis in a diabetic patient with renal allograft

Туберкулез и болезни лёгких, 2021
The article describes a clinical case of treatment of multiple drug resistant tuberculosis in the patient with type 1 diabetes mellitus who had received a kidney transplant (from his mother) 3 years before tuberculosis was diagnosed due to diabetic ...
E. V. Korzh, N. A. Podchos, T. V. Ivanitskaya   +2 more
doaj   +1 more source

Difficulty of tuberculosis diagnostics in general health care institutions

Клинический разбор в общей медицине, 2023
Aim. The aim of the study is to analyze the reasons for the erroneous diagnostics of TB in the general health care institutions and identify ways to improve diagnostics. Materials and methods.
Elena V. Korzh, Nina A. Podchos, Alexandr F. Zavgorodniy, Svetlana A. Iskevich   +3 more
doaj   +1 more source

Concomitant immunity to M. tuberculosis infection

Scientific Reports, 2022
Abstract Some persistent infections provide a level of immunity that protects against reinfection with the same pathogen, a process referred to as concomitant immunity. To explore the phenomenon of concomitant immunity during Mycobacterium tuberculosis infection, we utilized
Louis R. Joslyn, JoAnne L. Flynn, Denise E. Kirschner, Jennifer J. Linderman   +3 more
openaire   +3 more sources

Treatment efficacy and tuberculosis relapses in HIV infected patients with severe immunosuppression who started antiretroviral therapy

Туберкулез и болезни лёгких, 2020
The objective: to analyze treatment efficacy and causes of tuberculosis relapses in HIV-infected patients with severe immunosuppression who have started antiretroviral therapy (ART). Subjects and methods.
E. V. Korzh, N. A. Podchos, L. V. Striga, T. S. Izvekova, N. A. Malyavko   +4 more
doaj   +1 more source

Immunogenic Activity of Lipids of M. tuberculosis [PDF]

Nature, 1965
LIPIDS of mycobacteria are known to be immunogenically active components of tubercle bacilli1. First of all, it was surprising that mycobacteria contain lipids up to 35 per cent of their dry weight2. This fact did not escape the notice of immunologists.
B, Stöss, R, Herrmann
openaire   +2 more sources

M tuberculosis drug resistance in AIDS [PDF]

The Lancet, 1997
SIR—Bradford and associates (Oct 5, p 928) describe an increase of acquired drug resistance of Mycobacterium tuberculosis isolates chronologically associated with the trend of AIDSassociated tuberculosis in the USA between 1985 and 1994. The 14 resistant cases recorded were found to correlate with several behavioural and other individual factors within
DI PERRI, Giovanni, BONORA, Stefano, VENTO S., ALLEGRANZI B., CONCIA E.   +4 more
openaire   +3 more sources

Assessment of the Prevalence and Epidemic Spread of Strains of Ancient, and Modern Sublineages of the Mycobacterium tuberculosis Beijing Genotype in Omsk Region

Эпидемиология и вакцинопрофилактика, 2020
Relevance. The spread of the epidemic and resistant Mycobacterium tuberculosis genotypes presents a serious threat to the implementation of the national tuberculosis control program in Russia.
O. A. Pasechnik, A. A. Vyazovaya, A. I. Bloch, I. V. Yarusova, M. P. Tatarintseva, I. V. Mokrousov   +5 more
doaj   +1 more source

DYNAMICS OF DRUG RESISTANCE IN M. TUBERCULOSIS DURING THE NEW CORONAVIRUS INFECTION PANDEMIC IN DUSHANBE: THE NEED FOR URGENT MEASURES

Паёми Сино, 2022
Objective: To study the frequency and structure of primary and secondary drug resistance in M. tuberculosis (MTB) and risk factors for primary multidrug/rifampicin resistance (MDR/RR) in MTB before (Group I: 2018-2019) and during the COVID-19 pandemic ...
Z.KH. TILLOEVA
doaj   +1 more source

Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I

eLife, 2023
CD8+ T cell recognition of Mycobacterium tuberculosis (Mtb)-specific peptides presented on major histocompatibility complex class I (MHC-I) contributes to immunity to tuberculosis (TB), but the principles that govern presentation of Mtb antigens on MHC-I
Owen Leddy, Forest M White, Bryan D Bryson   +2 more
doaj   +1 more source